{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:58:50Z","timestamp":1777687130656,"version":"3.51.4"},"reference-count":22,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2016,3,31]]},"DOI":"10.3233\/jhd-150183","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T17:15:28Z","timestamp":1459444528000},"page":"33-38","source":"Crossref","is-referenced-by-count":6,"title":["Does the Mutant CAG Expansion in Huntingtin mRNA Interfere with Exonucleolytic Cleavage of its First Exon?"],"prefix":"10.1177","volume":"5","author":[{"given":"Wanzhao","family":"Liu","sequence":"first","affiliation":[{"name":"RNA Therapeutics Institute and Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith L.","family":"Pfister","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute and Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori A.","family":"Kennington","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute and Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn O.","family":"Chase","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute and Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[{"name":"Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"DiFiglia","sequence":"additional","affiliation":[{"name":"Mass General Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Aronin","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute and Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-150183_ref1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.3233\/JHD-150183_ref2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat Genet"},{"key":"10.3233\/JHD-150183_ref3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0959-4388(95)80072-7","article-title":"Huntington\u2019s disease: CAG genetics expands neurobiology","volume":"5","author":"Gusella","year":"1995","journal-title":"Curr Opin Neurobiol"},{"key":"10.3233\/JHD-150183_ref4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: From molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JHD-150183_ref5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12640-010-9227-6","article-title":"Modulation of mutant huntingtin N-terminal cleavage and its effect on aggregation and cell death","volume":"20","author":"Juenemann","year":"2011","journal-title":"Neurotox Res"},{"key":"10.3233\/JHD-150183_ref6","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: Parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-150183_ref7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.3233\/JHD-150183_ref8","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease","volume":"110","author":"Sathasivam","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.3233\/JHD-150183_ref9","doi-asserted-by":"crossref","first-page":"e1002481","DOI":"10.1371\/journal.pgen.1002481","article-title":"A pathogenic mechanism in Huntington\u2019s disease involves small CAG-repeated RNAs with neurotoxic activity","volume":"8","author":"Banez-Coronel","year":"2012","journal-title":"PLoS genetics"},{"key":"10.3233\/JHD-150183_ref10","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington\u2019s disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr Biol"},{"key":"10.3233\/JHD-150183_ref11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nmeth.1261","article-title":"Linking SNPs to CAG repeat length in Huntington\u2019s disease patients","volume":"5","author":"Liu","year":"2008","journal-title":"Nat Meth"},{"key":"10.3233\/JHD-150183_ref12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.molcel.2004.11.010","article-title":"mRNA turnover meets RNA interference","volume":"16","author":"Belostotsky","year":"2004","journal-title":"Molecular cell"},{"key":"10.3233\/JHD-150183_ref13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-150183_ref14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nmeth.1261","article-title":"Linking SNPs to CAG repeat length in Huntington\u2019s disease patients","volume":"5","author":"Liu","year":"2008","journal-title":"Nat Methods"},{"key":"10.3233\/JHD-150183_ref15","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/hmg\/2.10.1541","article-title":"Differential 3\u2032 polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression","volume":"2","author":"Lin","year":"1993","journal-title":"Human molecular genetics"},{"key":"10.3233\/JHD-150183_ref16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.3233\/JHD-150183_ref17","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.devcel.2008.05.012","article-title":"A silencing safeguard: Links between RNA silencing and mRNA processing in Arabidopsis","volume":"14","author":"Chen","year":"2008","journal-title":"Developmental cell"},{"key":"10.3233\/JHD-150183_ref18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1126\/science.1101092","article-title":"A link between mRNA turnover and RNA interference in Arabidopsis","volume":"306","author":"Gazzani","year":"2004","journal-title":"Science (New York, N Y)"},{"key":"10.3233\/JHD-150183_ref19","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4161\/rna.26706","article-title":"Aberrantly spliced HTT, a new player in Huntington\u2019s disease pathogenesis","volume":"10","author":"Gipson","year":"2013","journal-title":"RNA Biology"},{"key":"10.3233\/JHD-150183_ref20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.tins.2010.03.004","article-title":"Roles of trinucleotide-repeat RNA in neurological disease and degeneration","volume":"33","author":"Li","year":"2010","journal-title":"Trends in neurosciences"},{"key":"10.3233\/JHD-150183_ref21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tig.2004.08.004","article-title":"Pathogenic RNA repeats: An expanding role in genetic disease","volume":"20","author":"Ranum","year":"2004","journal-title":"Trends in genetics: TIG"},{"key":"10.3233\/JHD-150183_ref22","doi-asserted-by":"crossref","first-page":"e1002481","DOI":"10.1371\/journal.pgen.1002481","article-title":"A pathogenic mechanism in Huntington\u2019s disease involves small CAG-repeated RNAs with neurotoxic activity","volume":"8","author":"Banez-Coronel","year":"2012","journal-title":"PLoS Genet"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-150183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:08Z","timestamp":1777453028000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-150183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":22,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jhd-150183","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}